I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma


Gedik G. K. , Hoefnagel C. A. , Bais E., Olmos R. A. V.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.35, no.4, pp.725-733, 2008 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 4
  • Publication Date: 2008
  • Doi Number: 10.1007/s00259-007-0652-6
  • Title of Journal : EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Page Numbers: pp.725-733

Abstract

Purpose (131)Iodine metaiodobenzylguanidine (I-131-MIBG) is a radiopharmaceutical used for scintigraphic localisation of phaeochromocytomas and paragangliomas. The experience with its therapeutic use is limited. We report our experience for the treatment of malignant phaeochromocytoma and paraganglioma.